Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[MAOB: a modifier gene in phenylketonuria?].

Aline Ghozlan1, Arnold Munnich

  • 1Inserm U.393, Handicaps génétiques de l'enfant, Tour Lavoisier, Hôpital Necker-Enfants Malades, 149, rue de Sèvres, 75743 Paris 15, France. acghozlan@yahoo.fr

Medecine Sciences : M/S
|October 6, 2004
PubMed
Summary

Phenylketonuria (PKU) can cause cognitive issues due to phenylalanine buildup. Monoamine oxidase B (MAOB) may modify PKU severity by affecting toxic metabolite levels, potentially explaining varied patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal imaging reveals resilient memory networks in carriers of pathogenic ARID1B variants.

Translational psychiatry·2026
Same author

Systematic analysis of snRNA genes reveals frequent RNU2-2 variants in dominant and recessive developmental and epileptic encephalopathies.

Nature genetics·2026
Same author

No Correlation Between Interferon Signaling and Cytosolic Mitochondrial DNA/RNA Leakage in Cultured Skin Fibroblasts of Patients With Mitochondrial Diseases.

European journal of immunology·2026
Same author

Systematic analysis of snRNA genes reveals frequent <i>RNU2-2</i> variants in dominant and recessive developmental and epileptic encephalopathies.

medRxiv : the preprint server for health sciences·2025
Same author

Childhood POLG-related disorders: Focus on polyradiculoneuropathy.

Molecular genetics and metabolism·2025
Same author

Preconception carrier screening among assisted reproduction patients: insights from a monocentric survey in France.

Reproductive biomedicine online·2025

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Context:

  • Phenylketonuria (PKU) is a common inherited metabolic disorder.
  • Despite dietary management, PKU patients often face cognitive and behavioral challenges.
  • Variability in PKU phenotypes suggests genetic modifiers are at play.

Purpose:

  • To investigate the potential role of monoamine oxidase type B (MAOB) as a genetic modifier in PKU.
  • To explore how MAOB activity influences phenylethylamine levels and clinical outcomes in PKU patients.

Summary:

  • PKU results from phenylalanine hydroxylase deficiency, leading to toxic phenylalanine buildup.
  • MAOB degrades phenylethylamine, a toxic phenylalanine metabolite.
  • Variations in MAOB activity could explain differing clinical outcomes in PKU patients with similar phenylalanine levels.

Impact:

  • MAOB may act as a crucial modifier gene in PKU.
  • Understanding MAOB's role could lead to improved PKU management strategies.
  • Early-onset phenylethylamine toxicity, potentially mediated by low MAOB activity, may cause irreversible newborn brain damage in PKU.

Related Experiment Videos